Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin in stage II and III colon cancer
NCT02301286Phase 3Active, not recruiting
- Sponsor
- Leiden University
- Start
- Jan 2015
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in colon cancer, sponsored by Leiden University. Started Jan 2015; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT02301286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02301286.